NeoImmuneTech, Inc. (KOSDAQ:950220)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,188.00
+33.00 (2.86%)
Aug 14, 2025, 2:39 PM KST
2.86%
Market Cap114.19B
Revenue (ttm)183.62M
Net Income (ttm)-37.54B
Shares Out98.87M
EPS (ttm)-379.66
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,325,195
Average Volume1,994,211
Open1,155.00
Previous Close1,155.00
Day's Range1,141.00 - 1,239.00
52-Week Range985.00 - 1,881.00
Beta0.81
RSI49.63
Earnings DateAug 14, 2025

About NeoImmuneTech

NeoImmuneTech, Inc., a clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics. It is developing NT-I7, a clinical-stage long-acting human IL-7 for oncologic and infectious diseases. The company was incorporated in 2014 and is headquartered in Rockville, Maryland. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Employees 52
Stock Exchange KOSDAQ
Ticker Symbol 950220
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.